MPNRF | April 30, 2021
July 15, 2013
Recently the New England Journal of Medicine ran a letter to the editor drawing attention to a case in which an MF patient on Jakafi suffered an incidence of progressive multifocal leukoencephalopathy (PML) after starting therapy.
Research is ongoing as to whether this is an isolated incident or part of a larger issue with Jakafi. However, if you or your physician have questions about PML, contact Incyte at 1-855-463-3463.
